+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Akers Biosciences Inc (AKER) - Product Pipeline Analysis, 2019 Update

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Becton Dickinson and Co
  • Meridian Bioscience Inc
  • PositiveID Corp
  • MORE
Summary

Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRON, PIFA PLUSS PF4, tri-cholesterol, PIFA chlamydia, PIFA dengue fever, PIFA malaria, PIFA syphilis, PIFA heparin, and breath ketone. ABI provides testing platform technologies, which include micro particle catalyzed biosensor, particle immune-filtration assay, rapid enzymatic assay, rapid blood cell separation, and synthetic macrocycle complex. The company serves medical clinicians, individuals, corporations, and law enforcement agencies, health professionals. ABI is headquartered in West Deptford, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Akers Biosciences Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Becton Dickinson and Co
  • Meridian Bioscience Inc
  • PositiveID Corp
  • MORE
Akers Biosciences Inc Company Overview
  • Akers Biosciences Inc Company Snapshot
  • Akers Biosciences Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Akers Biosciences Inc – Pipeline Analysis Overview
  • Akers Biosciences Inc - Key Facts
  • Akers Biosciences Inc - Major Products and Services
  • Akers Biosciences Inc Pipeline Products by Development Stage
  • Akers Biosciences Inc Pipeline Products Overview
  • Breath PulmoHealth Check - Asthma
  • Breath PulmoHealth Check - Asthma Product Overview
  • Breath PulmoHealth Check - COPD
  • Breath PulmoHealth Check - COPD Product Overview
  • Breath PulmoHealth Check - Lung Cancer
  • Breath PulmoHealth Check - Lung Cancer Product Overview
  • BreathScan Asthma
  • BreathScan Asthma Product Overview
  • BreathScan DKA
  • BreathScan DKA Product Overview
  • BreathScan THC
  • BreathScan THC Product Overview
  • Diagnostic Test - Heart Attack
  • Diagnostic Test - Heart Attack Product Overview
  • Handheld Electronic Reader
  • Handheld Electronic Reader Product Overview
  • minDNAnalyzer
  • minDNAnalyzer Product Overview
  • PIFA Chlamydia Rapid Assay
  • PIFA Chlamydia Rapid Assay Product Overview
  • PIFA Hep B / Hep C
  • PIFA Hep B / Hep C Product Overview
  • PIFA HIV 1+2 Rapid Assay
  • PIFA HIV 1+2 Rapid Assay Product Overview
  • PIFA PLUSS - Troponin I
  • PIFA PLUSS - Troponin I Product Overview
  • PIFA PLUSS Malaria Rapid Assay
  • PIFA PLUSS Malaria Rapid Assay Product Overview
  • Akers Biosciences Inc - Key Competitors
  • Akers Biosciences Inc - Key Employees
  • Akers Biosciences Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Recent Developments
  • Akers Biosciences Inc, Recent Developments
  • May 20, 2019: Akers Biosciences reports Q1 2019 earnings
  • Apr 01, 2019: Akers Biosciences reports fiscal year 2018 earnings
  • Feb 05, 2019: Akers Biosciences: Further Re. Directorate change
  • Nov 15, 2018: Akers Biosciences announces Q3 2018 earnings
  • Nov 15, 2018: Akers Biosciences announces financial results for the three months and nine months ended September 30, 2018
  • Oct 19, 2018: Akers Biosciences has announced the directorate change
  • Oct 08, 2018: Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
  • Sep 13, 2018: Akers Biosciences: Directorate change - form 8-K filing
  • Aug 14, 2018: Akers Biosciences announces Q2 and H1 2018 earnings
  • Jul 18, 2018: Akers biosciences signs a further independent sales representative organization for Heparin PF4 Rapid Test covering additional 12 states
Appendix
  • Methodology
  • About the Author
  • Contact Us
  • Disclaimer
List of Tables
  • Akers Biosciences Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Akers Biosciences Inc Pipeline Products by Equipment Type
  • Akers Biosciences Inc Pipeline Products by Indication
  • Akers Biosciences Inc, Key Facts
  • Akers Biosciences Inc, Major Products and Services
  • Akers Biosciences Inc Number of Pipeline Products by Development Stage
  • Akers Biosciences Inc Pipeline Products Summary by Development Stage
  • Breath PulmoHealth Check - Asthma - Product Status
  • Breath PulmoHealth Check - Asthma - Product Description
  • Breath PulmoHealth Check - COPD - Product Status
  • Breath PulmoHealth Check - COPD - Product Description
  • Breath PulmoHealth Check - Lung Cancer - Product Status
  • Breath PulmoHealth Check - Lung Cancer - Product Description
  • BreathScan Asthma - Product Status
  • BreathScan Asthma - Product Description
  • BreathScan DKA - Product Status
  • BreathScan DKA - Product Description
  • BreathScan THC - Product Status
  • BreathScan THC - Product Description
  • Diagnostic Test - Heart Attack - Product Status
  • Diagnostic Test - Heart Attack - Product Description
  • Handheld Electronic Reader - Product Status
  • Handheld Electronic Reader - Product Description
  • minDNAnalyzer - Product Status
  • minDNAnalyzer - Product Description
  • PIFA Chlamydia Rapid Assay - Product Status
  • PIFA Chlamydia Rapid Assay - Product Description
  • PIFA Hep B / Hep C - Product Status
  • PIFA Hep B / Hep C - Product Description
  • PIFA HIV 1+2 Rapid Assay - Product Status
  • PIFA HIV 1+2 Rapid Assay - Product Description
  • PIFA PLUSS - Troponin I - Product Status
  • PIFA PLUSS - Troponin I - Product Description
  • PIFA PLUSS Malaria Rapid Assay - Product Status
  • PIFA PLUSS Malaria Rapid Assay - Product Description
  • Akers Biosciences Inc, Key Employees
  • Akers Biosciences Inc, Subsidiaries
  • Akers Biosciences Inc, Joint Venture
  • Glossary
List of Figures
  • Akers Biosciences Inc Pipeline Products by Equipment Type
  • Akers Biosciences Inc Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Meridian Bioscience Inc
  • Becton Dickinson and Co
  • PositiveID Corp
Note: Product cover images may vary from those shown
Adroll
adroll